薬物スクリーニング市場 : 2029年までの世界予測

出版：MarketsandMarkets（マーケッツアンドマーケッツ）　出版年月：2024年5月

Drug Screening Market – Global Forecast to 2029

薬物スクリーニング市場 : 製品 [迅速検査 (尿、経口)、分析 (呼気検知器、免疫測定、クロマトグラフィー)]、サンプル (尿、呼気、毛髪)、医薬品 (アルコール、大麻、オピオイド)、エンドユーザー (職場、病院、法律) – 2029年までの世界予測
Drug Screening Market by Product (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)), Sample (Urine, Breath, Hair), Drug (Alcohol, Cannabis, Opioids), End User (Workplace, Hospital, Law) – Global Forecast to 2029

お問合せ・ご注文　　出版社・価格・納期について

Report Overview

The global drug screening market is projected to reach USD 19.5 billion by 2029, from USD 9.1 billion in 2024, at a CAGR of 16.6%.

世界の薬物スクリーニング市場は、CAGR 16.6% で、2024 年の 91 億米ドルから 2029 年までに 195 億米ドルに達すると予測されています。

Factors such as enforcement of stringent laws mandating drug & alcohol testing, increasing drug & alcohol consumption, growing regulatory approvals for drug screening products & services. However, prohibits on alcohol consumption in Islamic countries and bans on workplace drug testing in particular countries may hamper the growth of this market to a definite extent.

“Drug screening services are expected to grow at the highest CAGR from 2024-2029”.
Drug screening market is divided into drug screening products and drug screening services. The services segment is stated to hold the highest growth rate during the forecast period, factors such increasing drug & alcohol consumption worldwide, geographic expansions of drug & alcohol testing laboratories, funding initiatives for drug testing laboratories, stringent laws regarding drug testing, and increasing approvals for drug tests contribute to the market.

“Analytical instrument segment to dominate the drug screening products market from 2024-2029”.
Drug screening products are divided into analytical instruments, rapid testing devices, and consumables. The analytical instruments segment holds for the largest share of the drug screening products market in 2023. Factors such as growing alcohol consumption, rising drunk driving & DUI cases, stringent government laws mandating drug & alcohol testing, and technological advancements in analytical instruments.However, the rapid testing devices market is stated to register the highest growth rate during the forecast period, owing to its constant requirement.

“By region, North America will dominate the market during 2024-2029.”
Geographically, the drug screening market is segmented into North America, Europe, the Asia Pacific, and Latin America, Middle East & Africa. In 2023, North America holds for the largest share of the drug screening market followed by Europe. However, Asia Pacific is deemed to register the highest growth rate during the forecast period. The high growth of this regional segment is credited due to the growing illicit consumption of drugs, stricter regulations are being implemented that require more frequent drug testing.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1: 57%, Tier 2: 30%, and Tier 3: 13%
• By Designation – C-level: 30%, D-level: 45%, and Others: 25%
• By Region – North America: 40%, Europe: 19%, Asia Pacific: 29%, Latin America: 7% and Middle East and Africa: 5%

Some of the prominent players operating in the drug screening market are Labcorp (US), Quest Diagnostics (US), Abbott (US), Thermo Fisher Scientific Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies Inc. (US), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), MPD Inc. (US), Shimadzu Corporation (Japan), Lifeloc Technologies, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Premier Biotech, Inc. (US), Omega Laboratories, Inc. (US), Psychemedics Corporation (US), Clinical Reference Laboratory, Inc. (US), American Bio Medica Corporation (US), ACM Global Laboratories (US), CareHealth America Corp (US), Sciteck, Inc. (US), Intoximeters, Inc. (US), AccuSourceHR, Inc. (US), Cordant Health Solutions (US), Intoxalock (US), Millennium Health (US).

Research Coverage:
The report dives into the global drug screening market, aiming to assess its current size and predict its future growth. It accomplishes this by segmenting the market based on various factors including product type, service type, sample collection method, end user, and geographical location. By understanding these market segments, the report offers insights into the opportunities available for businesses in this field. Additionally, it analyzes the factors that can influence the market’s growth, such as drivers, restraints, and opportunities. It also examines the competitive landscape, providing details on the major players in the market. Lastly, the report forecasts revenue for the market segments across four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: extensive information on drug screening offered by the top 25 players in the drug screening market. The report analyses the drug screening market by product and service, sample type, drug type, end user, and region.
• Analysis of key drivers (increase in drug abuse and alcohol consumption, enforcement of stringent laws,) restrains (ban on alcohol consumption on Islamic states), challenges (false positive and inaccurate results of breathalyzer), opportunities (oral fluid testing and emerging economies) are contributing the growth of the drug screening market.

• Market Development: Comprehensive information about economic emerging markets. The report analyses the markets for various drug screening across key geographic regions.

• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product/service launches in the drug screening market.

• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the drug screening market.

• Company profiling: In-depth assessment of company profiling and their market ranking and strategies of the leading players in the drug screening market.

Table of Contents

1            INTRODUCTION            71

1.1         STUDY OBJECTIVES      71

1.2         MARKET DEFINITION   71

1.2.1      INCLUSIONS AND EXCLUSIONS 72

1.3         STUDY SCOPE  73

1.3.1      MARKETS COVERED     73

FIGURE 1           DRUG SCREENING MARKET: MARKETS COVERED          73

1.3.2      REGIONS COVERED      74

FIGURE 2           DRUG SCREENING MARKET: REGIONS COVERED           74

1.3.3      YEARS CONSIDERED     74

1.3.4      CURRENCY CONSIDERED          75

1.4         MARKET STAKEHOLDERS          75

1.5         SUMMARY OF CHANGES            75

1.5.1      RECESSION IMPACT      76

2            RESEARCH METHODOLOGY     77

2.1         RESEARCH DATA           77

FIGURE 3           DRUG SCREENING MARKET: RESEARCH DESIGN            77

2.1.1      SECONDARY DATA       78

2.1.1.1   Key data from secondary sources     79

FIGURE 4           DRUG SCREENING MARKET: KEY DATA FROM SECONDARY SOURCES           79

2.1.2      PRIMARY DATA 79

FIGURE 5           DRUG SCREENING MARKET: PRIMARY SOURCES            80

2.1.2.1   Key data from primary sources         81

FIGURE 6           DRUG SCREENING MARKET: KEY DATA FROM PRIMARY SOURCES           81

2.1.2.2   Key industry insights          81

FIGURE 7           DRUG SCREENING MARKET: KEY INDUSTRY INSIGHTS 81

2.1.2.3   Breakdown of primary interviews     82

FIGURE 8           BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY, DESIGNATION, AND REGION           82

FIGURE 9           BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION             82

2.2         MARKET SIZE ESTIMATION       83

2.2.1      TOTAL MARKET SIZE ESTIMATION       83

2.2.2      REVENUE SHARE ANALYSIS       83

FIGURE 10         MARKET SIZE ESTIMATION (SUPPLY SIDE): REVENUE SHARE ANALYSIS          83

2.2.3      BOTTOM-UP APPROACH           85

FIGURE 11         DRUG SCREENING MARKET: BOTTOM-UP APPROACH 85

2.2.4      COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS           86

2.2.5      TOP-DOWN APPROACH             86

FIGURE 12         DRUG SCREENING MARKET: TOP-DOWN APPROACH   86

2.3         MARKET GROWTH FORECAST  87

FIGURE 13         CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029) 87

FIGURE 14         CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   88

2.4         MARKET BREAKDOWN AND DATA TRIANGULATION    89

FIGURE 15         DATA TRIANGULATION METHODOLOGY         89

2.5         STUDY ASSUMPTIONS  90

TABLE 1             DRUG SCREENING MARKET: STUDY ASSUMPTIONS      90

2.6         RISK ASSESSMENT         90

TABLE 2             DRUG SCREENING MARKET: RISK ASSESSMENT 90

2.7         RESEARCH LIMITATIONS           91

2.7.1      METHODOLOGY-RELATED LIMITATIONS         91

2.7.2      SCOPE-RELATED LIMITATIONS             91

2.8         IMPACT OF ECONOMIC RECESSION ON DRUG SCREENING MARKET              91

3            EXECUTIVE SUMMARY 92

FIGURE 16         DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION)     92

FIGURE 17         DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 93

FIGURE 18         DRUG SCREENING MARKET, BY DRUG TYPE, 2024 VS. 2029 (USD MILLION)          93

FIGURE 19         DRUG SCREENING MARKET, BY SAMPLE TYPE, 2024 VS. 2029 (USD MILLION) 94

FIGURE 20         DRUG SCREENING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)          95

FIGURE 21         REGIONAL SEGMENTATION OF DRUG SCREENING MARKET              96

4            PREMIUM INSIGHTS      97

4.1         DRUG SCREENING MARKET OVERVIEW 97

FIGURE 22         GROWING CONSUMPTION OF ILLICIT DRUGS AND ALCOHOL TO DRIVE MARKET       97

4.2         NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2023) 98

FIGURE 23         US AND DRUG SCREENING SERVICES TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD    98

4.3         DRUG SCREENING MARKET: REGIONAL MIX (2022–2029)            98

FIGURE 24         ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING STUDY PERIOD              98

4.4         DRUG SCREENING MARKET: GEOGRAPHICAL SNAPSHOT (2024–2029)              99

FIGURE 25         INDIA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD              99

4.5         DRUG SCREENING MARKET: DEVELOPED VS. EMERGING ECONOMIES (2024 VS. 2029)  99

FIGURE 26         EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD       99

5            MARKET OVERVIEW     100

5.1         INTRODUCTION            100

5.2         MARKET DYNAMICS     100

FIGURE 27         DRUG SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    100

5.2.1      DRIVERS            101

5.2.1.1   Growing consumption of illicit drugs and alcohol         101

5.2.1.2   Enforcement of stringent laws mandating drug and alcohol testing          101

5.2.1.3   Increasing number of regulatory approvals for drug screening products and services  102

TABLE 3             KEY PRODUCT AND SERVICE LAUNCHES FOR DRUG AND ALCOHOL TESTING, 2020–2022 102

TABLE 4             LIST OF REGULATORY AUTHORITIES FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES 102

5.2.2      RESTRAINTS     103

5.2.2.1   Ban on alcohol consumption in Islamic countries         103

5.2.2.2   Prohibition on workplace drug testing            103

5.2.3      OPPORTUNITIES           103

5.2.3.1   Popularity of oral fluid testing          103

5.2.3.2   Introduction of fingerprint-based drug testing at workplaces     103

5.2.3.3   High growth opportunities in emerging economies      104

5.2.4      CHALLENGES   104

5.2.4.1   Accuracy and specificity concerns in breathalyzers       104

5.2.4.2   False positive and negative results in drug screening    104

5.3         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 104

FIGURE 28         SHIFTS AND NEW REVENUE POCKETS FOR DRUG SCREENING MARKET            105

5.4         INDUSTRY TRENDS       105

5.4.1      INCREASING USE OF ORAL FLUID TESTING       105

5.4.2      GROWING NEED FOR SUBSTANCE TESTING PANELS     106

5.4.3      TECHNOLOGICAL ADVANCEMENTS     106

5.4.4      RISING FOCUS ON EMPLOYEE WELLNESS          107

5.5         VALUE CHAIN ANALYSIS            107

FIGURE 29         DRUG SCREENING MARKET: VALUE CHAIN ANALYSIS  108

5.6         ECOSYSTEM ANALYSIS 109

FIGURE 30         DRUG SCREENING MARKET: ECOSYSTEM MAP 109

TABLE 5             DRUG SCREENING MARKET: ROLE IN ECOSYSTEM        110

5.7         TECHNOLOGY ANALYSIS           110

5.7.1      KEY TECHNOLOGIES    110

5.7.1.1   Sweat patch testing            110

5.7.1.2   Alcohol ignition interlock device      111

5.7.1.3   Point-of-care testing          111

5.7.2      COMPLEMENTARY TECHNOLOGIES     111

5.7.2.1   Artificial Intelligence and machine learning   111

5.7.2.2   Biosensors           111

5.8         PORTER’S FIVE FORCES ANALYSIS         112

FIGURE 31         DRUG SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS              112

TABLE 6             DRUG SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS              113

5.8.1      INTENSITY OF COMPETITIVE RIVALRY 113

5.8.2      BARGAINING POWER OF SUPPLIERS     113

5.8.3      BARGAINING POWER OF BUYERS           113

5.8.4      THREAT OF SUBSTITUTES         114

5.8.5      THREAT OF NEW ENTRANTS    114

5.9         KEY STAKEHOLDERS AND BUYING CRITERIA    114

5.9.1      KEY STAKEHOLDERS IN BUYING PROCESS         114

FIGURE 32         INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS     114

TABLE 7             INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS             115

5.9.2      KEY BUYING CRITERIA 115

FIGURE 33         KEY BUYING CRITERIA FOR TOP THREE END USERS      115

TABLE 8             KEY BUYING CRITERIA FOR TOP THREE END USERS      115

5.10       TARIFF AND REGULATORY ANALYSIS   116

5.10.1    TARIFF ANALYSIS          116

5.10.1.1 Tariff of chromatography instruments (HS code: 902720)         116

TABLE 9             TARIFF FOR CHROMATOGRAPHY INSTRUMENTS (HS CODE: 902720) 116

5.10.2    REGULATORY ANALYSIS            116

5.10.2.1 North America     116

5.10.2.1.1            US         116

TABLE 10           US: DRUG AND ALCOHOL TESTING REGULATIONS       118

5.10.2.2 Europe  118

5.10.2.2.1            Finland  118

5.10.2.2.2            Sweden  119

5.10.2.2.3            France   119

5.10.2.2.4            Italy       119

5.10.2.2.5            UK         119

5.10.2.2.6            Netherlands         119

5.10.2.2.7            Ireland   119

5.10.2.3 Asia Pacific          120

5.10.2.3.1            Japan     120

5.10.2.3.2            China     120

5.10.2.3.3            India      120

5.10.2.4 Australia and New Zealand 120

5.10.2.5 Latin America      121

5.10.2.6 Middle East & Africa          121

5.10.3    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          121

TABLE 11           NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         121

TABLE 12           EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122

TABLE 13           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         123

TABLE 14           LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         124

TABLE 15           MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         124

5.11       PRICING ANALYSIS        124

5.11.1    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT              124

FIGURE 34         AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT         125

TABLE 16           AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT         125

5.11.2    INDICATIVE PRICING ANALYSIS             125

5.12       PATENT ANALYSIS        126

5.12.1    PATENT PUBLICATION TRENDS FOR DRUG SCREENING PRODUCTS              126

FIGURE 35         PATENT PUBLICATION TRENDS IN DRUG SCREENING MARKET (JANUARY 2012–DECEMBER 2023)        126

5.12.2    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS        126

FIGURE 36         TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DRUG SCREENING PATENTS (JANUARY 2012–NOVEMBER 2023)      127

FIGURE 37         TOP APPLICANT COUNTRIES/REGIONS FOR DRUG SCREENING PATENTS (JANUARY 2012–DECEMBER 2023)             128

TABLE 17           DRUG SCREENING MARKET: LIST OF MAJOR PATENTS 128

5.13       KEY CONFERENCES AND EVENTS IN 2024–2025 129

TABLE 18           DRUG SCREENING MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS    129

5.14       CASE STUDY ANALYSIS 130

5.14.1    LEADING RETAIL CHAIN TO SAVE USD 1 MILLION WITH INSTANT ORAL FLUID DRUG SCREENING SOLUTIONS     130

5.14.2    PRE-EMPLOYMENT TESTING IN LONG-TERM CARE INDUSTRY 131

5.14.3    USE OF HAIR TESTING AND URINALYSIS IN TRANSPORTATION INDUSTRY         131

5.14.4    RANDOM TESTING IN MANUFACTURING AND AUTOMOTIVE INDUSTRIES      131

5.15       REVENUE MODEL ANALYSIS     132

5.15.1    SERVICE FEES   132

5.15.2    PRODUCT SALES           132

5.15.3    SERVICE PACKAGES      132

5.16       END USER ANALYSIS     133

5.16.1    UNMET NEEDS 133

TABLE 19           UNMET NEEDS IN DRUG SCREENING MARKET 133

5.16.2    END USER EXPECTATIONS        134

TABLE 20           END USER EXPECTATIONS IN DRUG SCREENING MARKET              134

5.17       FUNDING LANDSCAPE 135

FIGURE 38         FUNDING OF KEY PLAYERS IN DRUG SCREENING MARKET              135

5.18       TRADE ANALYSIS          136

FIGURE 39         IMPORT DATA FOR CHROMATOGRAPHY (HS CODE 902720), BY COUNTRY, 2019–2023 (USD)       136

FIGURE 40         EXPORT DATA FOR CHROMATOGRAPHY (HS CODE 902720), BY COUNTRY, 2019–2023 (USD MILLION)    136

6            DRUG SCREENING MARKET, BY PRODUCT & SERVICE   137

6.1         INTRODUCTION            138

TABLE 21           DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)     138

TABLE 22           DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)     138

6.2         DRUG SCREENING SERVICES    138

TABLE 23           DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 139

TABLE 24           DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 139

TABLE 25           DRUG SCREENING SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)     139

TABLE 26           DRUG SCREENING SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)     140

6.2.1      LABORATORY TESTING SERVICES         140

6.2.1.1   Higher accuracy and better reliability to propel segment growth 140

TABLE 27           LABORATORY TESTING SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)          141

TABLE 28           LABORATORY TESTING SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)          142

6.2.2      ON-SITE TESTING SERVICES     142

6.2.2.1   Increasing emphasis on workplace safety to drive market           142

TABLE 29           ON-SITE TESTING SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 143

TABLE 30           ON-SITE TESTING SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 143

6.3         DRUG SCREENING PRODUCTS 144

TABLE 31           DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 144

TABLE 32           DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 144

TABLE 33           DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)     145

TABLE 34           DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)     146

6.3.1      ANALYTICAL INSTRUMENTS    146

6.3.1.1   Analytical instruments market, by type          146

TABLE 35           ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 147

TABLE 36           ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 147

TABLE 37           ANALYTICAL INSTRUMENT TYPES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)          148

TABLE 38           ANALYTICAL INSTRUMENT TYPES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)          149

6.3.1.1.1 Breathalyzers       149

TABLE 39           BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)              150

TABLE 40           BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)              150

TABLE 41           BREATHALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)          151

TABLE 42           BREATHALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)          152

6.3.1.1.1.1           Fuel-cell breathalyzers       152

6.3.1.1.1.1.1        High accuracy, sensitivity, and reliability to support segment growth              152

TABLE 43           FUEL-CELL BREATHALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)     153

TABLE 44           FUEL-CELL BREATHALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)     154

6.3.1.1.1.2           Semiconductor breathalyzers           154

6.3.1.1.1.2.1        Low cost and high accuracy to aid segment growth      154

TABLE 45           SEMICONDUCTOR BREATHALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)          155

TABLE 46           SEMICONDUCTOR BREATHALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)          156

6.3.1.1.1.3           Other breathalyzers           156

TABLE 47           OTHER BREATHALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 157

TABLE 48           OTHER BREATHALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 158

6.3.1.1.2 Immunoassay analyzers     158

6.3.1.1.2.1           Technological advancements and high demand for drug testing to drive segment 158

TABLE 49           IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 159

TABLE 50           IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 160

6.3.1.1.3 Chromatography instruments          160

6.3.1.1.3.1           More flexibility and higher accuracy to fuel segment growth      160

TABLE 51           CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)          161

TABLE 52           CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)          162

6.3.1.2   Analytical instruments market, by modality   162

TABLE 53           ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)     162

TABLE 54           ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)     163

TABLE 55           ANALYTICAL INSTRUMENT MODALITIES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)    163

TABLE 56           ANALYTICAL INSTRUMENT MODALITIES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)    164

6.3.1.2.1 Hand-held drug screening products 164

6.3.1.2.1.1           Rising need for quick alcohol intoxication level assessment to drive segment 164

TABLE 57           HAND-HELD DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)    165

TABLE 58           HAND-HELD DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)    166

6.3.1.2.2 Benchtop drug screening products   166

6.3.1.2.2.1           High sensitivity and specificity to different drugs at low concentrations to boost segment growth    166

TABLE 59           BENCHTOP DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)    167

TABLE 60           BENCHTOP DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)    168

6.3.2      RAPID TESTING DEVICES          168

TABLE 61           RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          168

TABLE 62           RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          169

TABLE 63           RAPID TESTING DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 169

TABLE 64           RAPID TESTING DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 170

6.3.2.1   Urine testing devices         170

TABLE 65           URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          170

TABLE 66           URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          171

TABLE 67           URINE TESTING DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 171

TABLE 68           URINE TESTING DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 172

6.3.2.1.1 Drug testing cups 172

6.3.2.1.1.1           Reduced chances of sample contamination to drive segment      172

TABLE 69           DRUG TESTING CUPS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)          173

TABLE 70           DRUG TESTING CUPS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)          174

6.3.2.1.2 Dip cards             174

6.3.2.1.2.1           No instrument requirements during urine testing to boost segment growth   174

TABLE 71           DIP CARDS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)              175

TABLE 72           DIP CARDS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)              176

6.3.2.1.3 Drug testing cassettes        176

6.3.2.1.3.1           Cost-effectiveness and quick results to augment segment growth              176

TABLE 73           DRUG TESTING CASSETTES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 177

TABLE 74           DRUG TESTING CASSETTES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 178

6.3.2.2   Oral fluid testing devices   178

6.3.2.2.1 Low possibility of sample tampering to aid market growth         178

TABLE 75           ORAL FLUID TESTING DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)     179

TABLE 76           ORAL FLUID TESTING DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)     180

6.3.3      CONSUMABLES 180

TABLE 77           CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)              180

TABLE 78           CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)              181

TABLE 79           CONSUMABLES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)          181

TABLE 80           CONSUMABLES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)          182

6.3.3.1   Assay kits             182

6.3.3.1.1 Increased focus on rapid, inexpensive, and convenient sample screening methods to drive market    182

TABLE 81           ASSAY KITS MARKET, BY COUNTRY 2018–2022 (USD MILLION)              183

TABLE 82           ASSAY KITS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)              184

6.3.3.2   Sample collection devices   184

6.3.3.2.1 Rising need for safe and efficient sample collection and transportation to propel market growth     184

TABLE 83           SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)     185

TABLE 84           SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)     186

6.3.3.3   Calibrators and controls     186

6.3.3.3.1 Growing need for quantitative comparison with actual test samples to fuel market growth   186

TABLE 85           CALIBRATORS AND CONTROLS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)     187

TABLE 86           CALIBRATORS AND CONTROLS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)     188

6.3.3.4   Other consumables            189

TABLE 87           OTHER CONSUMABLES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 189

TABLE 88           OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 190

7            DRUG SCREENING MARKET, BY SAMPLE TYPE  191

7.1         INTRODUCTION            192

TABLE 89           DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)          192

TABLE 90           DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)          192

7.2         URINE SAMPLES            193

7.2.1      EASE OF COLLECTION AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH        193

TABLE 91           DRUG SCREENING MARKET FOR URINE SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)    193

TABLE 92           DRUG SCREENING MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)    194

7.3         BREATH SAMPLES         194

7.3.1      RISING NUMBER OF DRIVING-UNDER-INFLUENCE CASES TO PROPEL MARKET GROWTH        194

TABLE 93           DRUG SCREENING MARKET FOR BREATH SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)    195

TABLE 94           DRUG SCREENING MARKET FOR BREATH SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)    196

7.4         ORAL FLUID SAMPLES  196

7.4.1      NON-INVASIVE SAMPLE COLLECTION AND LOW CHANCE OF ADULTERATION TO BOOST MARKET GROWTH             196

TABLE 95           DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)    197

TABLE 96           DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)    198

7.5         HAIR SAMPLES 198

7.5.1      DETAILED INSIGHTS INTO LONG-TERM DRUG USE TO SPUR MARKET GROWTH          198

TABLE 97           DRUG SCREENING MARKET FOR HAIR SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)          199

TABLE 98           DRUG SCREENING MARKET FOR HAIR SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)          200

7.6         OTHER SAMPLES           200

TABLE 99           DRUG SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)    201

TABLE 100         DRUG SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)    202

8            DRUG SCREENING MARKET, BY DRUG TYPE     203

8.1         INTRODUCTION            204

TABLE 101         DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)          204

TABLE 102         DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)          204

8.2         CANNABIS         205

8.2.1      INCREASING LEGALIZATION FOR MEDICAL AND RECREATIONAL PURPOSES TO DRIVE MARKET 205

TABLE 103         DRUG SCREENING MARKET FOR CANNABIS, BY COUNTRY, 2018–2022 (USD MILLION)          205

TABLE 104         DRUG SCREENING MARKET FOR CANNABIS, BY COUNTRY, 2023–2029 (USD MILLION)          206

8.3         ALCOHOL         206

8.3.1      RISING REGULATORY COMPLIANCE IN SAFETY-SENSITIVE INDUSTRIES TO DRIVE MARKET            206

TABLE 105         DRUG SCREENING MARKET FOR ALCOHOL, BY COUNTRY, 2018–2022 (USD MILLION)          207

TABLE 106         DRUG SCREENING MARKET FOR ALCOHOL, BY COUNTRY, 2023–2029 (USD MILLION)          208

8.4         COCAINE           208

8.4.1      ILLICIT NATURE AND ASSOCIATED HEALTH RISKS TO FUEL MARKET GROWTH          208

TABLE 107         DRUG SCREENING MARKET FOR COCAINE, BY COUNTRY, 2018–2022 (USD MILLION)          209

TABLE 108         DRUG SCREENING MARKET FOR COCAINE, BY COUNTRY, 2023–2029 (USD MILLION)          210

8.5         OPIOIDS            210

8.5.1      INCREASING CASES OF OPIOIDS ADDICTION TO AID MARKET GROWTH          210

TABLE 109         DRUG SCREENING MARKET FOR OPIOIDS, BY COUNTRY, 2018–2022 (USD MILLION)     211

TABLE 110         DRUG SCREENING MARKET FOR OPIOIDS, BY COUNTRY, 2023–2029 (USD MILLION)     211

8.6         AMPHETAMINE AND METHAMPHETAMINE      212

8.6.1      GROWING USE AMONG EDUCATION SERVICE EMPLOYEES TO AUGMENT MARKET GROWTH  212

TABLE 111         DRUG SCREENING MARKET FOR AMPHETAMINE AND METHAMPHETAMINE, BY COUNTRY, 2018–2022 (USD MILLION)             212

TABLE 112         DRUG SCREENING MARKET FOR AMPHETAMINE AND METHAMPHETAMINE, BY COUNTRY, 2023–2029 (USD MILLION)             213

8.7         OTHER DRUGS 213

TABLE 113        DRUG SCREENING MARKET FOR OTHER DRUGS, BY COUNTRY, 2018–2022 (USD MILLION)          214

TABLE 114        DRUG SCREENING MARKET FOR OTHER DRUGS, BY COUNTRY, 2023–2029 (USD MILLION)          215

9            DRUG SCREENING MARKET, BY END USER         216

9.1         INTRODUCTION            217

TABLE 115         DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)          217

TABLE 116         DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)          218

9.2         DRUG TESTING LABORATORIES            218

9.2.1      DRUG TESTING LABORATORIES TO COMMAND HIGHEST GROWTH RATE DURING STUDY PERIOD  218

TABLE 117         DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY COUNTRY, 2018–2022 (USD MILLION)          219

TABLE 118         DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY COUNTRY, 2023–2029 (USD MILLION)          220

9.3         WORKPLACES  220

9.3.1      INCREASED FOCUS ON RANDOM DRUG TESTING AT OFFICES TO FUEL MARKET GROWTH        220

TABLE 119         DRUG SCREENING MARKET FOR WORKPLACES, BY COUNTRY, 2018–2022 (USD MILLION)          221

TABLE 120         DRUG SCREENING MARKET FOR WORKPLACES, BY COUNTRY, 2023–2029 (USD MILLION)          222

9.4         CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES              222

9.4.1      GROWING GOVERNMENT FOCUS ON DRUG TESTING TO DRIVE MARKET            222

TABLE 121         DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2018–2022 (USD MILLION)              223

TABLE 122         DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2023–2029 (USD MILLION)              224

9.5         HOSPITALS       224

9.5.1      RISING DRUG ABUSE CASES TO AID MARKET GROWTH 224

TABLE 123         DRUG SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2018–2022 (USD MILLION)          225

TABLE 124         DRUG SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2023–2029 (USD MILLION)          226

9.6         DRUG TREATMENT CENTERS   226

9.6.1      GROWING GOVERNMENT SUPPORT AGAINST DRUG ABUSE TO DRIVE MARKET            226

TABLE 125        DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY COUNTRY, 2018–2022 (USD MILLION)            227

TABLE 126        DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY COUNTRY, 2023–2029 (USD MILLION)            228

9.7         INDIVIDUAL USERS       228

9.7.1      STRINGENT REGULATIONS AND PERSONAL SAFETY CONCERNS TO DRIVE MARKET 228

TABLE 127         DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY COUNTRY, 2018–2022 (USD MILLION)    229

TABLE 128         DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY COUNTRY, 2023–2029 (USD MILLION)    230

9.8         PAIN MANAGEMENT CENTERS 230

9.8.1      GROWING ABUSE OF PRESCRIPTION DRUGS TO DRIVE MARKET              230

TABLE 129         DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2018–2022 (USD MILLION)       231

TABLE 130         DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2023–2029 (USD MILLION)       232

9.9         SCHOOLS AND COLLEGES         232

9.9.1      RISING FOCUS ON DRUG ABUSE TESTING PROGRAMS TO SUPPORT MARKET GROWTH        232

TABLE 131         DRUG SCREENING MARKET FOR SCHOOLS AND COLLEGES, BY COUNTRY, 2018–2022 (USD MILLION)    233

TABLE 132         DRUG SCREENING MARKET FOR SCHOOLS AND COLLEGES, BY COUNTRY, 2023–2029 (USD MILLION)    234

9.10       OTHER END USERS        234

TABLE 133         DRUG SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2022 (USD MILLION)    235

TABLE 134         DRUG SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2029 (USD MILLION)    236

10          DRUG SCREENING MARKET, BY REGION            237

10.1       INTRODUCTION            238

TABLE 135         DRUG SCREENING MARKET, BY REGION, 2018–2022 (USD MILLION)          238

TABLE 136         DRUG SCREENING MARKET, BY REGION, 2023–2029 (USD MILLION)          238

10.2       NORTH AMERICA          239

FIGURE 41         NORTH AMERICA: DRUG SCREENING MARKET SNAPSHOT              239

TABLE 137         NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2018–2022 (USD MILLION)          240

TABLE 138         NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)          240

TABLE 139         NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)   240

TABLE 140         NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)   241

TABLE 141         NORTH AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)             241

TABLE 142         NORTH AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)             241

TABLE 143         NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)             242

TABLE 144         NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)             242

TABLE 145         NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)             242

TABLE 146         NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)             243

TABLE 147         NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)     243

TABLE 148         NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)     243

TABLE 149         NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)  244

TABLE 150         NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)  244

TABLE 151        NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          244

TABLE 152        NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          245

TABLE 153        NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          245

TABLE 154        NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          245

TABLE 155         NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)     246

TABLE 156         NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)     246

TABLE 157         NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)             246

TABLE 158         NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)             247

TABLE 159        NORTH AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)          247

TABLE 160        NORTH AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)          248

TABLE 161         NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)          248

TABLE 162         NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)          249

10.2.1    NORTH AMERICA: RECESSION IMPACT 249

10.2.2    US         250

10.2.2.1 US to dominate North American drug screening market during study period              250

TABLE 163         US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)          250

TABLE 164         US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)          251

TABLE 165         US: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 251

TABLE 166         US: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 251

TABLE 167         US: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)     251

TABLE 168         US: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)     252

TABLE 169         US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 252

TABLE 170         US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 252

TABLE 171         US: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          253

TABLE 172         US: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          253

TABLE 173         US: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)          253

TABLE 174         US: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)          254

TABLE 175         US: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 254

TABLE 176         US: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 254

TABLE 177         US: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 255

TABLE 178         US: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 255

TABLE 179         US: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          255

TABLE 180         US: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          256

TABLE 181         US: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION) 256

TABLE 182         US: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION) 256

TABLE 183         US: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION) 257

TABLE 184         US: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION) 257

TABLE 185         US: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)          258

TABLE 186         US: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)          258

10.2.3    CANADA            259

10.2.3.1 Increasing drunk driving-related accidental deaths to support market growth              259

TABLE 187         CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)       259

TABLE 188         CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)       260

TABLE 189         CANADA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          260

TABLE 190         CANADA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          260

TABLE 191         CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          261

TABLE 192         CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          261

TABLE 193         CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          261

TABLE 194         CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          262

TABLE 195         CANADA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          262

TABLE 196         CANADA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          262

TABLE 197         CANADA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)  263

TABLE 198         CANADA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)  263

TABLE 199         CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     263

TABLE 200         CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     264

TABLE 201         CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     264

TABLE 202         CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     264

TABLE 203         CANADA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          265

TABLE 204         CANADA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          265

TABLE 205         CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)     265

TABLE 206         CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)     266

TABLE 207         CANADA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)     266

TABLE 208         CANADA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)     267

TABLE 209         CANADA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION) 267

TABLE 210         CANADA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION) 268

10.3       EUROPE             268

TABLE 211         EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 269

TABLE 212         EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 269

TABLE 213        EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)          269

TABLE 214        EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)          270

TABLE 215         EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          270

TABLE 216         EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          270

TABLE 217         EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          271

TABLE 218         EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          271

TABLE 219         EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          271

TABLE 220         EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          272

TABLE 221         EUROPE: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          272

TABLE 222         EUROPE: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          272

TABLE 223         EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)  273

TABLE 224         EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)  273

TABLE 225         EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     273

TABLE 226         EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     274

TABLE 227         EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     274

TABLE 228         EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     274

TABLE 229         EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          275

TABLE 230         EUROPE: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          275

TABLE 231         EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)     275

TABLE 232         EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)     276

TABLE 233         EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)     276

TABLE 234         EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)     277

TABLE 235         EUROPE: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION) 277

TABLE 236         EUROPE: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION) 278

10.3.1    EUROPE: RECESSION IMPACT   278

10.3.2    GERMANY         278

10.3.2.1 Increasing number of drug-related deaths to drive market          278

TABLE 237         GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)       279

TABLE 238         GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)       279

TABLE 239         GERMANY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          279

TABLE 240         GERMANY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          280

TABLE 241         GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          280

TABLE 242         GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          280

TABLE 243         GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          281

TABLE 244         GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          281

TABLE 245         GERMANY: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 281

TABLE 246         GERMANY: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 282

TABLE 247         GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)  282

TABLE 248         GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)  282

TABLE 249         GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     283

TABLE 250         GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     283

TABLE 251         GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     283

TABLE 252         GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     284

TABLE 253         GERMANY: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          284

TABLE 254         GERMANY: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          284

TABLE 255         GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)          285

TABLE 256         GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)          285

TABLE 257         GERMANY: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)     286

TABLE 258         GERMANY: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)     286

TABLE 259         GERMANY: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)     287

TABLE 260         GERMANY: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)     287

10.3.3    FRANCE             288

10.3.3.1 Robust healthcare infrastructure and proactive approach toward public health to aid market growth              288

TABLE 261        FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)          288

TABLE 262        FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)          288

TABLE 263         FRANCE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     289

TABLE 264         FRANCE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     289

TABLE 265         FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          289

TABLE 266         FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          290

TABLE 267         FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          290

TABLE 268         FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          290

TABLE 269         FRANCE: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          291

TABLE 270         FRANCE: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          291

TABLE 271        FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)          291

TABLE 272        FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)          292

TABLE 273         FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     292

TABLE 274         FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     292

TABLE 275         FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     293

TABLE 276         FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     293

TABLE 277         FRANCE: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          293

TABLE 278         FRANCE: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          294

TABLE 279         FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)     294

TABLE 280         FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)     294

TABLE 281         FRANCE: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)     295

TABLE 282         FRANCE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)     295

TABLE 283         FRANCE: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION) 296

TABLE 284         FRANCE: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION) 296

10.3.4    UK         297

10.3.4.1 Increase in illicit drug consumption to augment market growth  297

TABLE 285         UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)          297

TABLE 286         UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)          297

TABLE 287         UK: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 298

TABLE 288         UK: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 298

TABLE 289         UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)     298

TABLE 290         UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)     298

TABLE 291         UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 299

TABLE 292         UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 299

TABLE 293         UK: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          299

TABLE 294         UK: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          300

TABLE 295         UK: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)          300

TABLE 296         UK: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)          300

TABLE 297         UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 301

TABLE 298         UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 301

TABLE 299         UK: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 301

TABLE 300         UK: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 302

TABLE 301         UK: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          302

TABLE 302         UK: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          302

TABLE 303         UK: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION) 303

TABLE 304         UK: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION) 303

TABLE 305         UK: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION) 304

TABLE 306         UK: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION) 304

TABLE 307         UK: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)          305

TABLE 308         UK: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)          305

10.3.5    ITALY   306

10.3.5.1 Growing consumption of illegal psychoactive substances and drugs among minors to boost market growth      306

TABLE 309         ITALY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)          306

TABLE 310         ITALY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)          306

TABLE 311         ITALY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     307

TABLE 312         ITALY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     307

TABLE 313         ITALY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)     307

TABLE 314         ITALY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)     308

TABLE 315         ITALY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)     308

TABLE 316         ITALY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)     308

TABLE 317         ITALY: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          309

TABLE 318         ITALY: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          309

TABLE 319         ITALY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)          309

TABLE 320         ITALY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)          310

TABLE 321         ITALY: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 310

TABLE 322         ITALY: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 310

TABLE 323         ITALY: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 311

TABLE 324         ITALY: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 311

TABLE 325         ITALY: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          311

TABLE 326         ITALY: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          312

TABLE 327         ITALY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)     312

TABLE 328         ITALY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)     312

TABLE 329         ITALY: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION) 313

TABLE 330         ITALY: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION) 313

TABLE 331         ITALY: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION) 314

TABLE 332         ITALY: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION) 314

10.3.6    SPAIN   315

10.3.6.1 Stringent government regulations and high consumption of alcohol to aid market growth   315

TABLE 333         SPAIN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)          315

TABLE 334         SPAIN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)          315

TABLE 335         SPAIN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     316

TABLE 336         SPAIN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     316

TABLE 337         SPAIN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)     316

TABLE 338         SPAIN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)     317

TABLE 339         SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)     317

TABLE 340         SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)     317

TABLE 341         SPAIN: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          318

TABLE 342         SPAIN: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          318

TABLE 343         SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)          318

TABLE 344         SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)          319

TABLE 345         SPAIN: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 319

TABLE 346         SPAIN: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 319

TABLE 347         SPAIN: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 320

TABLE 348         SPAIN: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 320

TABLE 349         SPAIN: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          320

TABLE 350         SPAIN: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          321

TABLE 351         SPAIN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)     321

TABLE 352         SPAIN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)     321

TABLE 353         SPAIN: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION) 322

TABLE 354         SPAIN: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION) 322

TABLE 355         SPAIN: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION) 323

TABLE 356         SPAIN: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION) 323

10.3.7    REST OF EUROPE           324

TABLE 357         REST OF EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)   324

TABLE 358         REST OF EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)   324

TABLE 359         REST OF EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)             325

TABLE 360         REST OF EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)             325

TABLE 361         REST OF EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)             325

TABLE 362         REST OF EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)             326

TABLE 363         REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, 2018–2022 (USD MILLION)     326

TABLE 364         REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)             326

TABLE 365         REST OF EUROPE: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)     327

TABLE 366         REST OF EUROPE: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)     327

TABLE 367         REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)  327

TABLE 368         REST OF EUROPE ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)  328

TABLE 369         REST OF EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          328

TABLE 370         REST OF EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          328

TABLE 371        REST OF EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          329

TABLE 372        REST OF EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          329

TABLE 373         REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)     329

TABLE 374         REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)     330

TABLE 375         REST OF EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)             330

TABLE 376         REST OF EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)             331

TABLE 377         REST OF EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)          331

TABLE 378         REST OF EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)          332

TABLE 379         REST OF EUROPE: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)          332

TABLE 380         REST OF EUROPE: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)          333

10.4       ASIA PACIFIC    333

FIGURE 42         ASIA PACIFIC: DRUG SCREENING MARKET SNAPSHOT  334

TABLE 381         ASIA PACIFIC: DRUG SCREENING MARKET, BY COUNTRY, 2018–2022 (USD MILLION)     334

TABLE 382         ASIA PACIFIC: DRUG SCREENING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)     335

TABLE 383         ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)       335

TABLE 384         ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)       335

TABLE 385         ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          336

TABLE 386         ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          336

TABLE 387         ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)             336

TABLE 388         ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)             337

TABLE 389         ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          337

TABLE 390         ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          337

TABLE 391         ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION) 338

TABLE 392         ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION) 338

TABLE 393         ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)  338

TABLE 394         ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)  339

TABLE 395         ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          339

TABLE 396         ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          339

TABLE 397         ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          340

TABLE 398         ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          340

TABLE 399         ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION) 340

TABLE 400         ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION) 341

TABLE 401         ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)          341

TABLE 402         ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)          341

TABLE 403         ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)          342

TABLE 404         ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)          342

TABLE 405         ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)     343

TABLE 406         ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)     343

10.4.1    ASIA PACIFIC: RECESSION IMPACT        344

10.4.2    JAPAN  344

10.4.2.1 Stringent laws for drug abuse and increased government support to drive market              344

TABLE 407         JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)          344

TABLE 408         JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)          345

TABLE 409         JAPAN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     345

TABLE 410         JAPAN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     345

TABLE 411         JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          345

TABLE 412         JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          346

TABLE 413         JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)     346

TABLE 414         JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)     346

TABLE 415         JAPAN: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          347

TABLE 416         JAPAN: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          347

TABLE 417         JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)          347

TABLE 418         JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)          348

TABLE 419         JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 348

TABLE 420         JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 348

TABLE 421         JAPAN: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 349

TABLE 422         JAPAN: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 349

TABLE 423         JAPAN: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          349

TABLE 424         JAPAN: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          350

TABLE 425         JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)     350

TABLE 426         JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)     350

TABLE 427         JAPAN: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION) 351

TABLE 428         JAPAN: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION) 351

TABLE 429         JAPAN: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION) 352

TABLE 430         JAPAN: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION) 352

10.4.3    CHINA  353

10.4.3.1 Increasing alcohol consumption and rising cases of drunk driving to fuel market growth   353

TABLE 431         CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)          353

TABLE 432         CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)          353

TABLE 433         CHINA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     354

TABLE 434         CHINA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     354

TABLE 435         CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          354

TABLE 436         CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          355

TABLE 437         CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)     355

TABLE 438         CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)     355

TABLE 439         CHINA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          356

TABLE 440         CHINA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          356

TABLE 441         CHINA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)          356

TABLE 442         CHINA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)          357

TABLE 443         CHINA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 357

TABLE 444         CHINA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 357

TABLE 445         CHINA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 358

TABLE 446         CHINA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 358

TABLE 447         CHINA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          358

TABLE 448         CHINA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          359

TABLE 449         CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)     359

TABLE 450         CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)     359

TABLE 451         CHINA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION) 360

TABLE 452         CHINA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION) 360

TABLE 453         CHINA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION) 361

TABLE 454         CHINA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION) 361

10.4.4    INDIA   362

10.4.4.1 Increase in illicit drug users and improved healthcare infrastructure to support market growth     362

TABLE 455         INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)          362

TABLE 456         INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)          362

TABLE 457         INDIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     363

TABLE 458         INDIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     363

TABLE 459         INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)     363

TABLE 460         INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)     364

TABLE 461         INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)     364

TABLE 462         INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)     364

TABLE 463         INDIA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          365

TABLE 464         INDIA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          365

TABLE 465         INDIA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)          365

TABLE 466         INDIA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)          366

TABLE 467         INDIA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 366

TABLE 468         INDIA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 366

TABLE 469         INDIA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 367

TABLE 470         INDIA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 367

TABLE 471         INDIA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          367

TABLE 472         INDIA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          368

TABLE 473         INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)     368

TABLE 474         INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)     368

TABLE 475         INDIA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION) 369

TABLE 476         INDIA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION) 369

TABLE 477         INDIA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION) 370

TABLE 478         INDIA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION) 370

10.4.5    REST OF ASIA PACIFIC  371

TABLE 479         REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)            371

TABLE 480         REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)            371

TABLE 481         REST OF ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)       372

TABLE 482         REST OF ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)       372

TABLE 483         REST OF ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)    372

TABLE 484         REST OF ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)    373

TABLE 485         REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)       373

TABLE 486         REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)       373

TABLE 487         REST OF ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          374

TABLE 488         REST OF ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          374

TABLE 489         REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)          374

TABLE 490         REST OF ASIA PACIFIC ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)          375

TABLE 491         REST OF ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)             375

TABLE 492         REST OF ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)             375

TABLE 493         REST OF ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)             376

TABLE 494         REST OF ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)             376

TABLE 495         REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          376

TABLE 496         REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          377

TABLE 497         REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)           377

TABLE 498         REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)           377

TABLE 499         REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)             378

TABLE 500         REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)             378

TABLE 501         REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)             379

TABLE 502         REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)             379

10.5       LATIN AMERICA             380

TABLE 503         LATIN AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2018–2022 (USD MILLION)          380

TABLE 504         LATIN AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)          380

TABLE 505         LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)       381

TABLE 506         LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)       381

TABLE 507         LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)             381

TABLE 508         LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)             382

TABLE 509         LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)             382

TABLE 510         LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)             382

TABLE 511         LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)             383

TABLE 512         LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)             383

TABLE 513         LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)     383

TABLE 514         LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)     384

TABLE 515         LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)  384

TABLE 516         LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)  384

TABLE 517         LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          385

TABLE 518         LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          385

TABLE 519         LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          385

TABLE 520         LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          386

TABLE 521         LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION) 386

TABLE 522         LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION) 386

TABLE 523         LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)             387

TABLE 524         LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)             387

TABLE 525         LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)          388

TABLE 526         LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)          388

TABLE 527         LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)          389

TABLE 528         LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)          389

10.5.1    LATIN AMERICA: RECESSION IMPACT   390

10.5.2    BRAZIL 390

10.5.2.1 Growing emphasis on substance abuse prevention at workplaces to drive market              390

TABLE 529         BRAZIL: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)          390

TABLE 530         BRAZIL: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)          391

TABLE 531         BRAZIL: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     391

TABLE 532         BRAZIL: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     391

TABLE 533         BRAZIL: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          392

TABLE 534         BRAZIL: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          392

TABLE 535         BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)     392

TABLE 536         BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)     393

TABLE 537         BRAZIL: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          393

TABLE 538         BRAZIL: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          393

TABLE 539         BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)          394

TABLE 540         BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)          394

TABLE 541         BRAZIL: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     394

TABLE 542         BRAZIL: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     394

TABLE 543         BRAZIL: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     395

TABLE 544         BRAZIL: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     395

TABLE 545         BRAZIL: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          395

TABLE 546         BRAZIL: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          396

TABLE 547         BRAZIL: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)     396

TABLE 548         BRAZIL: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)     396

TABLE 549         BRAZIL: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION) 397

TABLE 550         BRAZIL: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION) 397

TABLE 551         BRAZIL: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION) 398

TABLE 552         BRAZIL: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION) 398

10.5.3    MEXICO             399

10.5.3.1 Increasing government focus on controlling drug trafficking and substance abuse to propel market growth     399

TABLE 553        MEXICO: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)          399

TABLE 554        MEXICO: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)          399

TABLE 555         MEXICO: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          400

TABLE 556         MEXICO: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          400

TABLE 557         MEXICO: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          400

TABLE 558         MEXICO: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          401

TABLE 559         MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          401

TABLE 560         MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          401

TABLE 561         MEXICO: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          402

TABLE 562         MEXICO: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          402

TABLE 563        MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)          402

TABLE 564        MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)          403

TABLE 565         MEXICO: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     403

TABLE 566         MEXICO: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     403

TABLE 567         MEXICO: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)     404

TABLE 568         MEXICO: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)     404

TABLE 569         MEXICO: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          404

TABLE 570         MEXICO: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          405

TABLE 571         MEXICO: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)     405

TABLE 572         MEXICO: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)     405

TABLE 573         MEXICO: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)     406

TABLE 574         MEXICO: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)     406

TABLE 575         MEXICO: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION) 407

TABLE 576         MEXICO: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION) 407

10.5.4    REST OF LATIN AMERICA          408

TABLE 577         REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)            408

TABLE 578         REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)            408

TABLE 579         REST OF LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)    409

TABLE 580         REST OF LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)    409

TABLE 581         REST OF LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)    409

TABLE 582         REST OF LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)    410

TABLE 583         REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)    410

TABLE 584         REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)    410

TABLE 585         REST OF LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          411

TABLE 586         REST OF LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          411

TABLE 587         REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)       411

TABLE 588         REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)       412

TABLE 589         REST OF LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)       412

TABLE 590         REST OF LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)       412

TABLE 591         REST OF LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)       413

TABLE 592         REST OF LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)       413

TABLE 593         REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          413

TABLE 594         REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          414

TABLE 595         REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)           414

TABLE 596         REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)           414

TABLE 597         REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION) 415

TABLE 598         REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION) 415

TABLE 599         REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)             416

TABLE 600         REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)             416

10.6       MIDDLE EAST & AFRICA             417

TABLE 601         MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY REGION, 2018–2022 (USD MILLION)       417

TABLE 602         MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY REGION, 2023–2029 (USD MILLION)       417

TABLE 603         MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)            418

TABLE 604         MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)            418

TABLE 605        MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)       418

TABLE 606        MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)       419

TABLE 607         MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)    419

TABLE 608         MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)    419

TABLE 609         MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)    420

TABLE 610         MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)    420

TABLE 611         MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)          420

TABLE 612         MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)          421

TABLE 613         MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)       421

TABLE 614         MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)       421

TABLE 615         MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)       422

TABLE 616         MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)       422

TABLE 617         MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)       422

TABLE 618         MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)       423

TABLE 619         MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)          423

TABLE 620         MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)          423

TABLE 621         MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)           424

TABLE 622         MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)           424

TABLE 623         MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION) 424

TABLE 624         MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION) 425

TABLE 625         MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)             425

TABLE 626         MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)             426

10.6.1    MIDDLE EAST & AFRICA: RECESSION IMPACT   426

10.6.2    GCC COUNTRIES           426

10.6.2.1 Technological advancements in drug screening to drive market 426

TABLE 627         GCC COUNTRIES: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)       427

TABLE 628         GCC COUNTRIES: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)       427

TABLE 629         GCC COUNTRIES: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)             427

TABLE 630         GCC COUNTRIES: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)             428

TABLE 631         GCC COUNTRIES: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)             428

TABLE 632         GCC COUNTRIES: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)             428

TABLE 633         GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)             429

TABLE 634         GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)             429

TABLE 635         GCC COUNTRIES: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)     429

TABLE 636         GCC COUNTRIES: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)     430

TABLE 637         GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)  430

TABLE 638         GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)  430

TABLE 639         GCC COUNTRIES: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          431

TABLE 640         GCC COUNTRIES: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          431

TABLE 641         GCC COUNTRIES: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)          431

TABLE 642         GCC COUNTRIES: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)          431

TABLE 643         GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)     432

TABLE 644         GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)     432

TABLE 645         GCC COUNTRIES: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)             432

TABLE 646         GCC COUNTRIES: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)             433

TABLE 647         GCC COUNTRIES: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)          433

TABLE 648         GCC COUNTRIES: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)          434

TABLE 649         GCC COUNTRIES: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)          434

TABLE 650         GCC COUNTRIES: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)          435

10.6.3    REST OF MIDDLE EAST & AFRICA           435

TABLE 651         REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)      436

TABLE 652         REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)      436

TABLE 653         REST OF MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)    436

TABLE 654         REST OF MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)    437

TABLE 655         REST OF MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)          437

TABLE 656         REST OF MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)          437

TABLE 657         REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)    438

TABLE 658         REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)    438

TABLE 659         REST OF MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)       438

TABLE 660         REST OF MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)       439

TABLE 661         REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)       439

TABLE 662         REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)       439

TABLE 663         REST OF MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)    440

TABLE 664         REST OF MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)    440

TABLE 665         REST OF MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)    440

TABLE 666         REST OF MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)    441

TABLE 667         REST OF MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)             441

TABLE 668         REST OF MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)             441

TABLE 669         REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)     442

TABLE 670         REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)     442

TABLE 671         REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)         443

TABLE 672         REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)         443

TABLE 673         REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)            444

TABLE 674         REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)            444

11          COMPETITIVE LANDSCAPE       445

11.1       INTRODUCTION            445

11.2       KEY PLAYER STRATEGY/RIGHT TO WIN             445

FIGURE 43         DRUG SCREENING MARKET: STRATEGIES ADOPTED    446

11.3       REVENUE ANALYSIS      447

FIGURE 44         DRUG SCREENING MARKET: REVENUE ANALYSIS (2019–2023)              447

11.4       MARKET SHARE ANALYSIS         447

FIGURE 45         DRUG SCREENING MARKET: MARKET SHARE ANALYSIS (2023)              448

TABLE 675         DRUG SCREENING MARKET: DEGREE OF COMPETITION              448

11.4.1    MARKET RANKING ANALYSIS   449

FIGURE 46         DRUG SCREENING MARKET RANKING, BY KEY PLAYER (2023)              449

11.4.1.1 Laboratory Corporation of America Holdings 449

11.4.1.2 Quest Diagnostics              449

11.4.1.3 Abbott   450

11.5       BRAND/PRODUCT COMPARISON          450

FIGURE 47         DRUG SCREENING MARKET: BRAND/PRODUCT COMPARISON              450

11.6       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   451

11.6.1    STARS  451

11.6.2    EMERGING LEADERS    451

11.6.3    PERVASIVE PLAYERS     451

11.6.4    PARTICIPANTS 451

FIGURE 48         DRUG SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023     452

11.6.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      453

11.6.5.1 Overall footprint  453

TABLE 676         DRUG SCREENING MARKET: OVERALL FOOTPRINT      453

11.6.5.2 Product footprint 454

TABLE 677         DRUG SCREENING MARKET: PRODUCT FOOTPRINT     454

11.6.5.3 Service footprint  455

TABLE 678         DRUG SCREENING MARKET: SERVICE FOOTPRINT        455

11.6.5.4 Sample type footprint        456

TABLE 679         DRUG SCREENING MARKET: SAMPLE TYPE FOOTPRINT              456

11.6.5.5 Drug type footprint           457

TABLE 680         DRUG SCREENING MARKET: DRUG TYPE FOOTPRINT  457

11.6.5.6 Regional footprint              458

TABLE 681         DRUG SCREENING MARKET: REGIONAL FOOTPRINT    458

11.7       COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023         459

11.7.1    PROGRESSIVE COMPANIES       459

11.7.2    RESPONSIVE COMPANIES          459

11.7.3    DYNAMIC COMPANIES 459

11.7.4    STARTING BLOCKS       459

FIGURE 49         DRUG SCREENING MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023           460

11.7.5    COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023           461

TABLE 682         DRUG SCREENING MARKET: DETAILED LIST OF KEY START-UPS/SMES         461

TABLE 683         DRUG SCREENING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES          462

11.8       VALUATION AND FINANCIAL METRICS 462

FIGURE 50         EV/EBITDA OF KEY VENDORS   462

FIGURE 51         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 463

11.9       COMPETITIVE SCENARIO          463

11.9.1    PRODUCT/SERVICE LAUNCHES AND DEVELOPMENTS 463

TABLE 684         DRUG SCREENING MARKET: PRODUCT/SERVICE LAUNCHES AND DEVELOPMENTS, JANUARY 2021–APRIL 2024          463

11.9.2    DEALS  465

TABLE 685         DRUG SCREENING MARKET: DEALS, JANUARY 2021–APRIL 2024              465

11.9.3    OTHER DEVELOPMENTS           466

TABLE 686         DRUG SCREENING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2024         466

12          COMPANY PROFILES    467

12.1       KEY PLAYERS   467

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

12.1.1    LABORATORY CORPORATION OF AMERICA HOLDINGS             467

TABLE 687         LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW  467

FIGURE 52         LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2023)    468

TABLE 688         LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED   468

TABLE 689         LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS  469

12.1.2    QUEST DIAGNOSTICS   471

TABLE 690         QUEST DIAGNOSTICS: COMPANY OVERVIEW   471

FIGURE 53         QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2023)     471

TABLE 691         QUEST DIAGNOSTICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED          472

TABLE 692         QUEST DIAGNOSTICS: SERVICE LAUNCHES      472

TABLE 693         QUEST DIAGNOSTICS: DEALS   473

12.1.3    ABBOTT            475

TABLE 694         ABBOTT: COMPANY OVERVIEW             475

FIGURE 54         ABBOTT: COMPANY SNAPSHOT (2023) 476

TABLE 695         ABBOTT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 476

12.1.4    ORASURE TECHNOLOGIES INC.              479

TABLE 696         ORASURE TECHNOLOGIES INC.: COMPANY OVERVIEW 479

FIGURE 55         ORASURE TECHNOLOGIES INC.: COMPANY SNAPSHOT (2023)              480

TABLE 697         ORASURE TECHNOLOGIES INC.: PRODUCTS/SERVICES/

SOLUTIONS OFFERED  480

TABLE 698         ORASURE TECHNOLOGIES INC.: DEALS 481

12.1.5    ALFA SCIENTIFIC DESIGNS INC.              483

TABLE 699         ALFA SCIENTIFIC DESIGNS INC.: COMPANY OVERVIEW 483

TABLE 700         ALFA SCIENTIFIC DESIGNS INC.: PRODUCTS/SERVICES/

SOLUTIONS OFFERED  483

12.1.6    THERMO FISHER SCIENTIFIC INC.          485

TABLE 701         THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW              485

FIGURE 56         THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)   486

TABLE 702         THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/

SOLUTIONS OFFERED  486

TABLE 703         THERMO FISHER SCIENTIFIC INC.: PRODUCT DEVELOPMENTS           490

TABLE 704         THERMO FISHER SCIENTIFIC INC.: DEALS          490

12.1.7    DRÄGERWERK AG & CO. KGAA 491

TABLE 705         DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW  491

FIGURE 57         DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023)              492

TABLE 706         DRÄGERWERK AG & CO. KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED   493

TABLE 707         DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES AND APPROVALS      493

12.1.8    LIFELOC TECHNOLOGIES, INC. 494

TABLE 708         LIFELOC TECHNOLOGIES, INC.: COMPANY OVERVIEW 494

FIGURE 58         LIFELOC TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)              494

TABLE 709         LIFELOC TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED   495

12.1.9    MPD INC.           497

TABLE 710         MPD INC.: COMPANY OVERVIEW           497

TABLE 711         MPD INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED              498

12.1.10  OMEGA LABORATORIES, INC.   499

TABLE 712         OMEGA LABORATORIES, INC.: COMPANY OVERVIEW    499

TABLE 713         OMEGA LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED   499

TABLE 714         OMEGA LABORATORIES, INC.: SERVICE LAUNCHES       500

TABLE 715         OMEGA LABORATORIES, INC.: DEALS   500

TABLE 716         OMEGA LABORATORIES, INC.: OTHER DEVELOPMENTS              500

12.1.11  PREMIER BIOTECH, INC.            501

TABLE 717         PREMIER BIOTECH, INC.: COMPANY OVERVIEW             501

TABLE 718         PREMIER BIOTECH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED          501

12.1.12  PSYCHEMEDICS CORPORATION            503

TABLE 719         PSYCHEMEDICS CORPORATION: COMPANY OVERVIEW              503

FIGURE 59         PSYCHEMEDICS CORPORATION: COMPANY SNAPSHOT (2023)              503

TABLE 720         PSYCHEMEDICS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED   504

12.1.13  F. HOFFMANN-LA ROCHE LTD. 505

TABLE 721         F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 505

FIGURE 60         F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)              506

TABLE 722         F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED   507

12.1.14  SHIMADZU CORPORATION       508

TABLE 723         SHIMADZU CORPORATION: COMPANY OVERVIEW        508

FIGURE 61         SHIMADZU CORPORATION: COMPANY SNAPSHOT (2023)              509

TABLE 724         SHIMADZU CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED   510

TABLE 725         SHIMADZU CORPORATION: PRODUCT LAUNCHES        510

12.1.15  SIEMENS HEALTHINEERS AG    511

TABLE 726         SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW     511

FIGURE 62         SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)              512

TABLE 727         SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED   513

TABLE 728         SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES     514

TABLE 729         SIEMENS HEALTHINEERS AG: DEALS    514

12.2       OTHER PLAYERS           515

12.2.1    AMERICAN BIO MEDICA CORPORATION            515

TABLE 730         AMERICAN BIO MEDICA CORPORATION: COMPANY OVERVIEW        515

12.2.2    ACM GLOBAL LABORATORIES  516

TABLE 731         ACM GLOBAL LABORATORIES: COMPANY OVERVIEW  516

12.2.3    CAREHEALTH AMERICA CORP. 517

TABLE 732         CAREHEALTH AMERICA CORP.: COMPANY OVERVIEW 517

12.2.4    CLINICAL REFERENCE LABORATORY, INC.         518

TABLE 733         CLINICAL REFERENCE LABORATORY, INC.: COMPANY OVERVIEW        518

12.2.5    INTOXIMETERS 519

TABLE 734         INTOXIMETERS: COMPANY OVERVIEW 519

12.2.6    SCITECK, INC.   520

TABLE 735         SCITECK, INC.: COMPANY OVERVIEW   520

12.2.7    ACCUSOURCEHR, INC.  521

TABLE 736         ACCUSOURCEHR, INC.: COMPANY OVERVIEW  521

12.2.8    CORDANT HEALTH SOLUTIONS            522

TABLE 737         CORDANT HEALTH SOLUTIONS: COMPANY OVERVIEW              522

12.2.9    INTOXALOCK   523

TABLE 738         INTOXALOCK: COMPANY OVERVIEW    523

12.2.10  MILLENNIUM HEALTH 523

TABLE 739         MILLENNIUM HEALTH: COMPANY OVERVIEW  523

12.2.11  ADVACARE PHARMA    524

TABLE 740         ADVACARE PHARMA: COMPANY OVERVIEW     524

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13          APPENDIX         525

13.1       DISCUSSION GUIDE      525

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             530

13.3       CUSTOMIZATION OPTIONS      532

13.4       RELATED REPORTS       532

13.5       AUTHOR DETAILS         533